Colon Cancer’s Unexpected Target

Elite marathon runners, paragons of peak fitness, show a shocking 15% rate of precancerous colon polyps—far beyond the expected 1-2%—challenging the myth that extreme endurance always shields against cancer.

Story Snapshot

Dr. Timothy Cannon’s study of 100 marathoners aged 35-50 found 15% with advanced adenomas versus 1-2% expected.
41% had any adenoma, compared to under 10% in average-risk peers.
Findings stem from real cases of young ultramarathoners dying from advanced colorectal cancer despite healthy lifestyles.
Experts caution: small, non-peer-reviewed study; exercise overall cuts cancer risk, but extremes may harm the gut.
Call for runners with rectal bleeding to seek colonoscopy, not dismiss as “runner’s colitis.”

Dr. Cannon Spots Deadly Pattern in Ultramarathoners

Dr. Timothy Cannon, medical oncologist at Inova Schar Cancer Institute, treated multiple ultramarathoners under 40 with advanced colorectal cancer. These fit athletes lacked family history or inflammatory bowel disease. Two died, including Josh Wadlington, who ran seven marathons in seven days. Wadlington ignored bloody stools as training fallout. Their families aided recruitment for Cannon’s study. This cluster defied norms where exercise protects against cancer.

Cannon hypothesized repeated gut stress from extreme running promotes polyps. Long runs divert blood from intestines to muscles, causing ischemia. This “runner’s colitis” brings pain and bleeding. Over time, inflammation might damage DNA, fostering adenomas. Facts align with common sense: moderation builds health, excess invites injury—even in virtues like discipline.

Prospective Study Reveals Alarming Colonoscopy Results

Cannon enrolled 100 runners aged 35-50, each completing at least five marathons or two ultramarathons. None had hereditary risks or bowel disease. All underwent screening colonoscopies. Results hit at the 2025 ASCO Annual Meeting in Chicago: 15% showed advanced adenomas, precancerous growths needing removal. Expected rate in this low-risk group: 1-2%. Overall, 41% had adenomas versus under 10% anticipated. Average age: 42.5, below standard screening at 45.

Study lacked a direct control group, comparing to population data. Presented as an abstract, not peer-reviewed journal. Inova called it “groundbreaking” in August 2025 press release. Media from Fox News to Cancer Today amplified findings. Conservative values prize personal responsibility; runners must heed body signals, not chase extremes blindly.

Counterintuitive Clash with Exercise Benefits

Epidemiology long proves regular activity slashes colorectal cancer risk. Guidelines tout exercise as protective. Yet Cannon’s work spotlights extremes: ultramarathons stressing guts beyond moderate runs studied before. Ischemia cycles may mutate cells in susceptible runners. Most early-onset cancers strike non-athletes, tied to diet or environment. This flags elite endurance as niche risk. Facts demand balance—push limits wisely, screen symptoms promptly.

Colorectal cancer rises in under-50s, prompting U.S. screening drop to 45. Cannon’s cases fit this trend but highlight athletes normalizing bleeds. Common sense prevails: fitness fortifies, but ignoring red flags courts tragedy. Runners report GI woes; doctors now probe deeper.

Clinical Shifts and Runner Realities

Oncologists lower thresholds for colonoscopies in symptomatic runners under 45. Cannon urges persistence with exercise—overall benefits hold—but evaluate rectal bleeding seriously. No guidelines changed yet; more studies needed. Race organizers may update health advisories. Athletes weigh glory against gut health. Early detection saves lives; delaying for “toughness” defies prudence.

Short-term: heightened awareness cuts complacency. Long-term, if confirmed, runners join high-risk screening pools. Insurers might cover earlier scopes. Sports culture shifts from enduring pain to seeking care. American conservatism favors self-reliance through vigilance, not denial.